Health

Results: 7561-7572 of 8680

Zamas Lam, PhD, Global Head of Bioanalytical (Mass Spec) & Preclinical Development, QPS LLC. (Photo: Business Wire)

QPS Significantly Enhances Mass Spectrometry Laboratory Capacity

Medidata Secures Top Honors in Everest Group's Decentralized Clinical Trial Platforms PEAK Matrix® Assessment

PR Newswire associated0

More accurate tumour treatment thanks to superconductive ASG Superconductors technology

Pulsenmore Receives Brazilian ANVISA Approval for Its Prenatal Home Ultrasound Solution

Fermion announces IND Approval of Non-Addictive Pain Relief Drug FZ008-145 by China NMPA

Fortrea Establishes Industry Partnership with Veeva and Advarra to Streamline Patient and Site Clinical Trial Experience

Vertex Announces Approval of First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™, for the Treatment of Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT) in Kingdom of Saudi Arabia

PR Newswire associated0

Lifespan Vision Ventures invests in Bolden Therapeutics

DeepBrain AI Delivers AI Avatar to Empower People with Disabilities

PR Newswire associated0

Venatorx Pharmaceuticals and Menarini Group Enter Commercial Agreement for Cefepime-Taniborbactam in 96 Countries

MedaSystems Secures Additional Funding from Debiopharm Innovation Fund to Accelerate Global Access to Pre-approval Treatment

Example of HistoSonics technology targeting kidney tissue to be destroyed in a non-invasive histotripsy procedure. (Photo: Business Wire)

World’s First Kidney Tumor Treated Using the HistoSonics’ Edison® Histotripsy System